{
  "trial_id": "NCT04731961",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "participation, she will be consented for study participation and the Botox injection",
      "label": "met"
    },
    {
      "criterion": "procedure.",
      "label": "met"
    },
    {
      "criterion": "Prior to receiving treatment, patients will complete a 3-day voiding diary and the following questionnaires: Incontinence Impact Questionnaire short form (IIQ-7) and Urogenital Distress Inventory short form (UDI-6) at the time of consent.",
      "label": "met"
    },
    {
      "criterion": "Patients in both arms will receive prophylactic antibiotics (oral nitrofurantoin or cephalexin) to complete prior to the procedure date.",
      "label": "met"
    },
    {
      "criterion": "On the day of treatment, patients will have a clean catch urine specimen obtained and urine dip completed.",
      "label": "met"
    },
    {
      "criterion": "Patients who have a positive urine dip will have her procedure rescheduled to another day.",
      "label": "met"
    },
    {
      "criterion": "A 70-degree cystoscope will be inserted through the urethra and into the bladder until the trigone is identified; the bladder will be distended with approximately 200 mL sterile saline.",
      "label": "met"
    },
    {
      "criterion": "100 units of Botox will be mixed with 10 mL of Normal Saline for sterile injection into the bladder.",
      "label": "met"
    },
    {
      "criterion": "In the reduced protocol arm, a single row of 5 injections will be administered into the detrusor muscle.",
      "label": "met"
    },
    {
      "criterion": "In the standard protocol arm, 3 rows of 5 injections will be administered into the detrusor muscle.",
      "label": "met"
    },
    {
      "criterion": "Approximately 5 minutes post-procedure, patients will rate their pain experienced during the procedure using a 100-point visual analog pain scale.",
      "label": "met"
    },
    {
      "criterion": "If the patient is unable to void post-procedure, she will be taught how to perform clean intermittent self-catheterization (CISC) and provided with a log to record void and catheter volumes.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Current symptomatic urinary tract infection that has not resolved prior to randomization.",
      "label": "does_not_trigger"
    },
    {
      "criterion": "Baseline need for intermittent self-catheterization",
      "label": "triggers"
    },
    {
      "criterion": "PVR (Post void residual) >150 mL on 2 occasions with void(s) of greater than 150 mL",
      "label": "triggers"
    },
    {
      "criterion": "Surgical treatment for stress incontinence (sling, Burch or urethral injection) or pelvic organ prolapse recommended or planned at enrollment by study investigator(s).",
      "label": "triggers"
    },
    {
      "criterion": "Any prior intra-detrusor botulinum toxin A injections",
      "label": "triggers"
    },
    {
      "criterion": "Previous or currently implanted neuromodulation (sacral or tibial).",
      "label": "triggers"
    },
    {
      "criterion": "Surgically altered detrusor muscle, such as augmentation cystoplasty.",
      "label": "triggers"
    },
    {
      "criterion": "Known allergy to botulinum toxin A.",
      "label": "triggers"
    }
  ],
  "notes": "67-year-old healthy woman with no underlying disease. She works at a rehab center and has no allergies to any food or drugs.",
  "_meta": {
    "topic_id": "69",
    "trial_id": "NCT04731961",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}